Autor: |
Drexel, H, Coats, AJS, Spoletini, I, Bilato, C, Mollace, V, Perrone Filardi, P, Rosano, GMC |
Jazyk: |
angličtina |
Rok vydání: |
2020 |
Předmět: |
|
ISSN: |
2055-6845 |
Popis: |
Benefits and safety on statins have been well-established over 20 years of research. Despite this, the vast majority of patients are not adequately treated and do not achieve the low-density lipoprotein cholesterol target levels. This is mainly due to poor adherence, which is associated with dangerous and sometimes fatal outcomes. To increase adherence and prevent worse outcomes, a combination therapy with lower dosage of statins and new lipid-lowering drugs may be used. However, the implementation of new lipid-lowering drugs in European countries is still at the beginning. For these reasons, the aim of this position paper is to give an up-to-date indication from the ESC Working Group on Cardiovascular Pharmacotherapy in order to discuss the barriers towards statins adherence and new lipid-lowering drugs implementation in Europe. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|